Compare CRMD & AVK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRMD | AVK |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 509.9M | 498.9M |
| IPO Year | 2009 | 2003 |
| Metric | CRMD | AVK |
|---|---|---|
| Price | $7.22 | $12.02 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $15.20 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 185.5K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 780.00 | N/A |
| EPS | ★ 2.04 | N/A |
| Revenue | ★ $311,709,000.00 | N/A |
| Revenue This Year | $0.30 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.51 | ★ N/A |
| Revenue Growth | ★ 617.03 | N/A |
| 52 Week Low | $6.13 | $10.44 |
| 52 Week High | $17.43 | $13.10 |
| Indicator | CRMD | AVK |
|---|---|---|
| Relative Strength Index (RSI) | 59.78 | 55.88 |
| Support Level | $6.14 | $10.77 |
| Resistance Level | $7.44 | $12.56 |
| Average True Range (ATR) | 0.24 | 0.28 |
| MACD | 0.12 | 0.08 |
| Stochastic Oscillator | 82.89 | 89.25 |
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
Advent Convertible & Income Fund is a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The Fund invests in various sectors, such as communications, utilities, energy, industrial, technology, and others.